RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Raia Drogasil S/A Stock

Raia Drogasil S/A Market capitalization 2025

Raia Drogasil S/A Market capitalization

24.82 B BRL

Ticker

RADL3.SA

ISIN

BRRADLACNOR0

In 2025, Raia Drogasil S/A's market cap stood at 24.82 B BRL, a -45.96% increase from the 45.94 B BRL market cap in the previous year.

The Raia Drogasil S/A Market capitalization history

YEARMarket Capitalization (undefined BRL)
202443.24
202345.08
202236.57
202141.39
202038.29
201925.92
201822.9
201722.48
201618.17
201511.33
20141.24
20131.27
20121.26
20110.72
20100.4
20090.2
20080.14
20070.18
20060.03
20050.01

Raia Drogasil S/A Aktienanalyse

What does Raia Drogasil S/A do?

Raia Drogasil SA is a Brazilian company specializing in the sale of pharmaceutical and personal care products. The company is based in São Paulo, Brazil, and operates throughout Latin America. Raia Drogasil was founded in 1905 and is now the largest retail company in Brazil specializing in the sale of drugs and personal care products. Raia Drogasil started as a small family business and over the years, through acquisitions and mergers, became one of the largest retailers in Brazil. The company opened its first pharmacy in São Paulo and expanded its presence throughout the entire territory of Brazil. Today, Raia Drogasil operates approximately 2,200 branches in over 25 states in Brazil. Raia Drogasil's innovative business model is focused on digitalized processes and customer service, ensuring a smooth and user-friendly experience for customers. The company has adapted its business operations in the past due to environmental changes and societal trends. For example, Raia Drogasil has recently strengthened its e-commerce business, allowing customers to conveniently and securely order from home. Raia Drogasil SA operates two different brands: Drogasil and Droga Raia. The Drogasil brand is established more in cities, while the Droga Raia brand is active in smaller towns. Both brand branches offer a wide range of health and beauty products, including drugs, supplements, cosmetics, and baby products. Products offered by Raia Drogasil include general health medications such as pain relievers, vitamins, and cough and cold remedies. Additionally, the company also offers a wide range of products for specific health issues, such as products for diabetics, skincare, and women's well-being. They also carry supplements for various needs, such as immune system support, cardiovascular issues, muscle building, and weight loss. Raia Drogasil also provides a wide selection of cosmetic products for body care and beauty, including skincare and haircare products, makeup, and perfumes. Another special offering is the baby and children's department, where you can find a variety of products for babies and children of all ages, such as baby creams, wipes, and milk powder. In summary, Raia Drogasil SA is one of the leading companies in the pharmacy and personal care industry in Brazil. The company specializes in providing health products to its customers and offers a wide range of products for various needs. This includes medications, supplements, cosmetic products, baby products, and much more. Raia Drogasil has also successfully adapted to ever-changing environmental conditions and societal trends to ensure a smooth and user-friendly experience for its customers. Raia Drogasil S/A ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Raia Drogasil S/A's Market Capitalization

Raia Drogasil S/A's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Raia Drogasil S/A's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Raia Drogasil S/A's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Raia Drogasil S/A’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Raia Drogasil S/A stock

What is the current Raia Drogasil S/A market capitalization?

The current market capitalization of Raia Drogasil S/A is 24.82 B BRL.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Raia Drogasil S/A.

How has the market capitalization of Raia Drogasil S/A developed in recent years?

The market capitalization of Raia Drogasil S/A has increased/decreased by -45.96% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Raia Drogasil S/A?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Raia Drogasil S/A?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Raia Drogasil S/A have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Raia Drogasil S/A pay?

Over the past 12 months, Raia Drogasil S/A paid a dividend of 0.34 BRL . This corresponds to a dividend yield of about 2.25 %. For the coming 12 months, Raia Drogasil S/A is expected to pay a dividend of 0.38 BRL.

What is the dividend yield of Raia Drogasil S/A?

The current dividend yield of Raia Drogasil S/A is 2.25 %.

When does Raia Drogasil S/A pay dividends?

Raia Drogasil S/A pays a quarterly dividend. This is distributed in the months of January, May, May, August.

How secure is the dividend of Raia Drogasil S/A?

Raia Drogasil S/A paid dividends every year for the past 25 years.

What is the dividend of Raia Drogasil S/A?

For the upcoming 12 months, dividends amounting to 0.38 BRL are expected. This corresponds to a dividend yield of 2.51 %.

In which sector is Raia Drogasil S/A located?

Raia Drogasil S/A is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Raia Drogasil S/A kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Raia Drogasil S/A from 1/1/2026 amounting to 0.077 BRL, you needed to have the stock in your portfolio before the ex-date on 7/4/2025.

When did Raia Drogasil S/A pay the last dividend?

The last dividend was paid out on 1/1/2026.

What was the dividend of Raia Drogasil S/A in the year 2024?

In the year 2024, Raia Drogasil S/A distributed 0.308 BRL as dividends.

In which currency does Raia Drogasil S/A pay out the dividend?

The dividends of Raia Drogasil S/A are distributed in BRL.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Raia Drogasil S/A

Our stock analysis for Raia Drogasil S/A Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Raia Drogasil S/A Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.